Filing Details
- Accession Number:
- 0001209191-20-057068
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-04 21:34:51
- Reporting Period:
- 2020-11-02
- Accepted Time:
- 2020-11-04 21:34:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786386 | J. Justin Mcanear | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2020-11-02 | 7,100 | $5.04 | 8,033 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 1,324 | $135.40 | 6,709 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 4,376 | $136.10 | 2,333 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 500 | $137.10 | 1,833 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 500 | $137.99 | 1,333 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-02 | 400 | $139.21 | 933 | No | 4 | S | Direct | |
| Class A Common Stock | Acquisiton | 2020-11-03 | 2,900 | $5.04 | 3,833 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 200 | $135.55 | 3,633 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 1,000 | $136.54 | 2,633 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 1,600 | $137.57 | 1,033 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2020-11-03 | 100 | $138.73 | 933 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2020-11-02 | 7,100 | $0.00 | 7,100 | $5.04 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2020-11-03 | 2,900 | $0.00 | 2,900 | $5.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 512,900 | 2028-11-02 | No | 4 | M | Direct | |
| 510,000 | 2028-11-02 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $134.84 to $135.77. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $135.85 to $136.84. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $136.85 to $137.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $137.85 to $138.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $139.19 to $139.23. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $135.09 to $136.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $136.09 to $136.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $137.20 to $138.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This option, originally for 600,000 shares, of which 87,100 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- This option, originally for 600,000 shares, of which 90,000 shares have been exercised, vested as to one-fourth of the shares on October 8, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Billionaire Hedge Funds
